Donor cell leukemia in a patient developing 11 months after an allogeneic bone marrow transplantation for chronic myeloid leukemia

Date

2006

Authors

Ataergin, S.
Arpaci, F.
Cetin, T.
Guran, s.
Yakicier, C.
Beyzadeoglu, M.
Ozet, A.

Editor(s)

Advisor

Supervisor

Co-Advisor

Co-Supervisor

Instructor

Source Title

American Journal of Hematology

Print ISSN

0361-8609

Electronic ISSN

1096-8652

Publisher

Wiley

Volume

81

Issue

5

Pages

370 - 373

Language

English

Journal Title

Journal ISSN

Volume Title

Series

Abstract

A 38‐year‐old female with chronic myeloid leukemia underwent an allogeneic bone marrow transplantation from her full‐matched brother. Eleven months later, she readmitted with an acute leukemia that was shown to be of donor origin. The patient never achieved a remission even after chemotherapies with cytarabine and mitoxantrone, donor lymphocyte infusion, and second allogeneic peripheral blood stem cell transplantation. Donor cell leukemia (DCL) is sometimes misdiagnosed as relapse by clinicians and the real incidence may be higher than expected. Cytogenetic and molecular techniques may be helpful to clarify the issue of the leukemia. The current case is another case of DCL reported in the literature after an allogeneic transplant for a kind of leukemia. Am. J. Hematol. 81:370–373, 2006

Course

Other identifiers

Book Title

Citation